PHAT R&D Expense Growth
Phathom Pharmaceuticals Inc · R&D Expense Growth
PHAT R&D Expense Growth
Latest reported0.54%period ending
PHAT Quarterly R&D Growth (QoQ) (0.00% → 0.54%)
Latest values, visible window
High-resolution chart · PNG
PHAT r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 0.5405% | |
| 3.7101% | |
| 6.6316% | |
| -22.576% | |
| -1.176% | |
| 7.0022% | |
| -1.2654% | |
| 17.8552% | |
| -21.7815% | |
| -29.5901% | |
| 9.2147% | |
| -3.9251% | |
| 11.1944% | |
| -28.0133% | |
| -16.1619% | |
| 1.0896% | |
| 6.5402% | |
| 30.3033% | |
| -18.3947% | |
| -23.1004% | |
| 4.9417% | |
| -50.593% | |
| 61.6376% | |
| 73.4302% | |
| -6.341% | |
| 24.8819% | |
| 184.2694% | |
| -94.5279% | |
| 18,937.0629% | |
| 2,964.2857% | |
| 133.3333% | |
| 0% | |
| 0% | |
| 0% |